You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Novavax begins phase III coronavirus vaccine trial in the UK

Novavax has initiated a phase III study of its COVID-19 vaccine candidate in the UK, which will aim to enrol up to 10,000 volunteers.